MedPath

Effect of Pneumatic Intermittent Venous Compression on Fluid Volumes Infused During Major Abdominal Surgery

Not Applicable
Withdrawn
Conditions
Major Abdominal Surgery
Interventions
Device: Intermittent pneumatic compression
Procedure: Standard care
Registration Number
NCT01403909
Lead Sponsor
Centre Hospitalier Universitaire de Nīmes
Brief Summary

The main objective of this study was to evaluate the effect of intermittent pneumatic venous compression on intra-operative fluid intake by comparing two groups of patients with or without intermittent pneumatic compression of the lower limbs.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • The patient must have given his/her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • Patient with ASA score 1-3
  • Body mass index < 30 kg/m^2
  • Patient is schelduled for major abdominal surgery (laparotomy without risk of haemorrhage whose duration is assumed to be greater than 120 min)
  • The patient passes from home, directly to the hospital, without schelduled hospitalization in another department
Exclusion Criteria
  • The patient is participating in another study
  • The patient is in an exclusion period determined by a previous study
  • The patient is under judicial protection, under tutorship or curatorship
  • The patient refuses to sign the consent
  • It is impossible to correctly inform the patient
  • The patient is pregnant
  • The patient is breastfeeding
  • The patient has a contra-indication for treatment necessary for the study
  • ASA score > 3
  • body mass index > 30 kg/m^2
  • Expected surgical time of < 120 minutes
  • Surgery with risk of hemorrhage
  • Surgery via celioscopy
  • The surgery require perineal access, thus rendering any blinding impossible
  • Hepatic surgery
  • Contra indication for intermittent venous compression

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
With compressionIntermittent pneumatic compressionThe patients randomized to this group will have intermittent pneumatic venous compression of the lower limbs during surgery.
Without compressionStandard careThe patients randomized to this group will not have intermittent pneumatic venous compression of the lower limbs during surgery. (Standard care)
Primary Outcome Measures
NameTimeMethod
Volume fluids (ml)End of surgery (expected mean of 2 hours)

The total volume of infused fluids (Ringer's Lactate and HES) delivered to the patient during surgery (ml)

Secondary Outcome Measures
NameTimeMethod
Hypotensive episodesend of surgery (expected mean of 2 hours)

The number of arterial hypotension episodes (systolic pressure \< 90 mmHg)

VEGFend of surgery (expected mean of 2 hours)

Concentration (pg/ml) of Vascular Endothelial Growth Factor (VEGF) in blood

sFlt1end of surgery (expected mean of 2 hours)

Concentration (pg/ml) of soluble vascular endothelial growth factor receptor-1 (sFlt1) in blood

Albuminend of surgery (expected mean of 2 hours)

Albuminemia (g/l)

Days of hospitalization28 days

Length of hospitalization (days)

Hematocrit %end of surgery (expected mean of 2 hours)
Presence/absence of POSSUM complications28 days

Presence/absence of complications as defined by the Physiological and Operative Severity Score for the Enumeration of Mortality and Morbidity (POSSUM) criteria

Number of days not in hospital28 days

Number of days not in hospital

Prothrombin (%)end of surgery (expected mean of 2 hours)

Prothrombin rate in blood

Activated partial thromboplastin timeend of surgery (expected mean of 2 hours)

Activated partial thromboplastin time (seconds)

Trial Locations

Locations (1)

Centre Hospitalier Universitaire de Nîmes

🇫🇷

Nîmes Cedex 09, Gard, France

© Copyright 2025. All Rights Reserved by MedPath